The invention provides novel compounds having the general formula (I) wherein R1, R2 and R3 are as described herein, and compositions including the compounds. The use of the compounds as inhibitors of hormone sensitive lipose (HSL) for the treatment of diseases such as diabetes and metabolic symdrome is also disclosed.